STAT – The FDA on Friday approved a landmark rare disease treatment — the first to rely on a Nobel-prize-winning technique known as RNA interference, which silences disease-causing genes.
The Guardian – Most Americans are blind to the opioid epidemic in their own backyards, a study shows, despite predictions the crisis could claim more than half a million lives in the US by 2027.
Pew Research Center – Americans are more likely to anticipate negative than positive effects from widespread use of gene-editing technology.
Gizmodo – Internal documents from IBM show that medical experts working with the company’s Watson supercomputer found “multiple examples of unsafe and incorrect treatment recommendations”.
Nano and Other Emerging Chemical Technologies Blog – The final debate at the Forum used nanomaterials as a case study to argue whether product stewardship can replace regulation.
Nature – Gene-edited crops should be subject to the same stringent regulations as conventional genetically modified organisms (GMOs), Europe’s highest court ruled today.
The New York Times – Hoover Dam helped transform the American West. Now it is the focus of a new challenge: turning the dam into a vast reservoir of excess electricity, fed by the solar farms and wind turbines that represent the power sources of the future.
Engadget – DARPA is launching an Artificial Intelligence Exploration program that will invest in new AI concepts, including "third wave" AI with contextual adaptation and an ability to explain its decisions in ways that make sense.
US News & World Report – A new report from the health insurance industry shows signs of progress in curbing the nation's opioid epidemic.
PropertyCasualty360 – People are naturally afraid of change. When that change comes in the form of potentially relinquishing control over a basic function like driving, fear is accompanied by skepticism.
CNN – Women who have given birth five or more times may be 70% more likely to develop Alzheimer's later in life than those who have fewer births, according to a new study of more than 3,500 women in South Korea and Greece.